Development of atopic dermatitis is assessed according to an algorithm described in detail under "9. Outcome measures", which uses information on prescriptions and hospitalizations up until one year after the last age of outcome assessment (1 year of age in this study) to confirm a case. Children must therefore be alive and living in Denmark until 2 years of age representative of age at end of follow-up plus 1 year.